...an NS5A inhibitor . TaiGen will contribute its Greater China rights to furaprevir ( TG-2349...
...Pharm Group , Dongguan, China TaiGen Biopharmaceuticals Holdings Ltd. (TPex:4157), Taipei, Taiwan Business: Infectious Nora Weintraub DAG-181 NS5A inhibitor TG-2349 HEC...

...and TaiGen will contribute its Greater China rights to HCV protease inhibitor furaprevir ( TG-2349...

...Exviera dasabuvir from AbbVie Inc. (NYSE:ABBV); Olysio simeprevir from Johnson & Johnson (NYSE:JNJ); furaprevir ( TG-2349...

...experienced investors coming in." In addition to Taigexyn and burixafor, TaiGen is developing furaprevir ( TG-2349...